Coho Partners, Ltd. Abbott Laboratories Transaction History

Coho Partners, Ltd.

$2.71 Billion
Q3 2024

A detailed history of Coho Partners, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Coho Partners, Ltd. holds 683,469 shares of ABT stock, worth $78.4 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

683,469

Previous 767,720 10.97%

Holding current value

$78.4 Million

Previous $79.8 Million 2.32%

% of portfolio

2.88%

Previous 2.81%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $8.43 Million - $9.95 Million	-84,251 Reduced 10.97%	683,469 $77.9 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $4.48 Million - $5 Million	-44,491 Reduced 5.48%	767,720 $79.8 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $8.58 Million - $9.48 Million	-78,352 Reduced 8.8%	812,211 $92.3 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $58.4 Million - $71.4 Million	646,972 Added 265.6%	890,563 $98 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $5,445 - $6,533	57 Added 0.02%	243,591 $23.6 Million
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $22.4 Million - $25 Million	222,223 Added 1042.76%	243,534 $26.6 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $113,423 - $133,505	1,171 Added 5.81%	21,311 $2.16 Million
Q3 2022 Oct 07, 2022	SELL	$96.76 - $112.03 $13,643 - $15,796	-141 Reduced 0.7%	20,140 $1.95 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $25,007 - $30,225	-245 Reduced 1.19%	20,281 $2.2 Million
Q4 2021 Jan 14, 2022	BUY	$115.53 - $141.46 $9,820 - $12,024	85 Added 0.42%	20,526 $2.89 Million
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $144,191 - $159,518	-1,236 Reduced 5.7%	20,441 $2.42 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $60,935 - $71,729	576 Added 2.73%	21,677 $2.51 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $175,341 - $206,578	-1,611 Reduced 7.09%	21,101 $2.53 Million
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $224,700 - $244,858	-2,140 Reduced 8.61%	22,712 $2.49 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $104 Million - $127 Million	-1,139,045 Reduced 97.86%	24,852 $2.71 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $29.8 Million - $38.2 Million	-389,607 Reduced 25.08%	1,163,897 $106 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $2.13 Million - $3.12 Million	-33,952 Reduced 2.14%	1,553,504 $123 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $1.82 Million - $2.03 Million	23,225 Added 1.48%	1,587,456 $138 Million
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $44.1 Million - $47.8 Million	-539,069 Reduced 25.63%	1,564,231 $131 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $42 Million - $49 Million	-576,655 Reduced 21.52%	2,103,300 $177 Million
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $4.06 Million - $4.91 Million	61,355 Added 2.34%	2,679,955 $214 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $6.74 Million - $7.64 Million	102,819 Added 4.09%	2,618,600 $189 Million
Q3 2018 Oct 29, 2018	SELL	$60.81 - $73.36 $3.85 Million - $4.64 Million	-63,231 Reduced 2.45%	2,515,781 $185 Million
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $4.11 Million - $4.54 Million	71,437 Added 2.85%	2,579,012 $157 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $48 Million - $54.3 Million	-853,475 Reduced 25.39%	2,507,575 $150 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $6.43 Million - $6.88 Million	-119,744 Reduced 3.44%	3,361,050 $192 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $12.1 Million - $13.5 Million	-252,273 Reduced 6.76%	3,480,794 $186 Million
Q2 2017 Aug 07, 2017	BUY	N/A	3,733,067	3,733,067 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coho Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coho Partners, Ltd. with notifications on news.

Account

Coho Partners, Ltd. Abbott Laboratories Transaction History